Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 2
2005 1
2006 1
2009 1
2011 5
2012 3
2014 1
2015 5
2017 3
2018 8
2019 14
2020 10
2021 12
2022 14
2023 20
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
Komatsu H, Matsumoto K, Morita M, Nagasawa T, Nishio H, Suzuki J, Nishio S, Kobara H, Yunokawa M, Ariyoshi K, Hirayama T, Tokunaga H, Ukita M, Yoriki K, Mori-Uchino M, Furusawa A, Togami S, Nakamura H, Ishikawa M, Satoh T. Komatsu H, et al. Among authors: ishikawa m. Cancer Med. 2024 Mar;13(5):e6968. doi: 10.1002/cam4.6968. Cancer Med. 2024. PMID: 38491829 Free PMC article.
Hydrogel spacer injection to the meso-sigmoid to protect the sigmoid colon in cervical cancer brachytherapy: A technical report.
Sakuramachi M, Murakami N, Nagao A, Kojima K, Miyata Y, Kashihara T, Kaneda T, Takahashi K, Inaba K, Okuma K, Nakayama Y, Okamoto H, Ishikawa M, Igaki H. Sakuramachi M, et al. Among authors: ishikawa m. J Contemp Brachytherapy. 2023 Dec;15(6):465-469. doi: 10.5114/jcb.2023.134174. Epub 2023 Dec 29. J Contemp Brachytherapy. 2023. PMID: 38230404 Free PMC article.
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma.
Kojima Y, Yoshida H, Okuya T, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Noguchi E, Shimoi T, Tamura K, Tanase Y, Uno M, Ishikawa M, Arakaki M, Ichikawa H, Yagishita S, Hamada A, Fujiwara Y, Yonemori K, Kato T. Kojima Y, et al. Among authors: ishikawa m. Gynecol Oncol Rep. 2023 Nov 14;50:101302. doi: 10.1016/j.gore.2023.101302. eCollection 2023 Dec. Gynecol Oncol Rep. 2023. PMID: 38054200 Free PMC article.
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
Onuki M, Takahashi F, Iwata T, Nakazawa H, Yahata H, Kanao H, Horie K, Konnai K, Nio A, Takehara K, Kamiura S, Tsuda N, Takei Y, Shigeta S, Matsumura N, Yoshida H, Motohara T, Yamazaki H, Nakamura K, Hamanishi J, Tasaka N, Ishikawa M, Hirashima Y, Kudaka W, Mori-Uchino M, Kukimoto I, Fujii T, Watanabe Y, Noda K, Yoshikawa H, Yaegashi N, Matsumoto K; MINT Study Group. Onuki M, et al. Among authors: ishikawa m. Cancer Sci. 2023 Nov;114(11):4426-4432. doi: 10.1111/cas.15943. Epub 2023 Sep 8. Cancer Sci. 2023. PMID: 37688310 Free PMC article.
Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis.
Hiranuma K, Asami Y, Kato MK, Murakami N, Shimada Y, Matsuda M, Yazaki S, Fujii E, Sudo K, Kuno I, Komatsu M, Hamamoto R, Makinoshima H, Matsumoto K, Ishikawa M, Kohno T, Terao Y, Itakura A, Yoshida H, Shiraishi K, Kato T. Hiranuma K, et al. Among authors: ishikawa m. Cancer Med. 2023 Sep;12(17):17835-17848. doi: 10.1002/cam4.6415. Epub 2023 Aug 3. Cancer Med. 2023. PMID: 37537783 Free PMC article.
99 results